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Inhibition of gap junctional intercellular communication (GJIC) and
the activation of intracellular mitogenic pathways are common hall-
marks of epithelial derived cancer cells. We previously determined
that the 1-methyl and not the 2-methyl isomer of anthracene, which
are prominent cigarette smoke components, activated extracellular
receptor kinase, and inhibited GJIC in WB-F344 rat liver epithelial
cells. Using these same cells, we show that an immediate upstream
response to 1-methylanthracene was a rapid (<1 min) release of
arachidonic acid. Inhibition of phosphatidylcholine-specific pho-
spholipase C prevented the inhibition of GJIC by 1-methylanthracene.
In contrast, inhibition of phosphatidylinositol specific phospholipase
C, phospholipase A2, diacylglycerol lipase, phospholipase D, pro-
tein kinase C, and tyrosine protein kinases had no effect on 1-
methylanthracene-induced inhibition of GJIC. Inhibition of protein
kinase A also prevented inhibition of GJIC by 1-methylanthracene.
Direct measurement of phosphatidylcholine-specific phospholipase
C and sphingomyelinase indicated that only phosphatidylcholine-
specific phospholipase C was activated in response to 1-methy-
lanthracene, while 2-methylanthracene had no effect. 1-methylanthracene
also activated p38-mitogen activated protein kinase; however,
like extracellular kinase, its activation was not involved in 1-
methylanthracene-induced regulation of GJIC, and this activation
was independent of phosphatidylcholine-specific phospholipase
C. Although mitogen activated protein kinases were activated,
Western blot analyzes indicated no change in connexin43 pho-
sphorylation status. Our results indicate that phosphatidylcholine-
specific phospholipase C is an important enzyme in the induction of
a tumorigenic phenotype, namely the inhibition of GJIC; whereas
mitogen activated protein kinases triggered in response to 1-
methylanthracene, were not involved in the deregulation of
GJIC. (Cancer Sci 2008; 99: 696–705)
C onsiderable toxicological and carcinogenic research onpolycyclic aromatic hydrocarbons (PAH) has focused on
the genotoxic attributes of these compounds.(1) However, many
human diseases, such as cancer, are not solely the consequence
of non-reversible mutagenic events, but also include reversible,
epigenetic events (altered expression of genes at transcriptional,
translational and post-translational levels) that alter the normal
phenotype of a cell.(2) Thus, there is a need to reassess the
toxicity and carcinogenicity of environmental toxicants,
including PAH, at the epigenetic level. Rosenkranz et al.(3)
showed that out of a group of 251 chemicals, there was actually
a much stronger correlation of tumorigenicity with the inhibition
of gap junctional intercellular communication (GJIC), an
epigenetic event, than with mutagenicity. Cell proliferative
diseases such as cancer include crucial epigenetic events that
ultimately remove quiescent initiated-cells from the growth
suppressive control of neighboring cells.(2,4) Intercellular
communication between contiguous cells via protein com-
plexes, known as gap junctions, also alters, epigenetically, the
expression of genes and strongly suggests that intercellular
signaling can further modulate the intracellular signal
transduction pathways.(5–7)
Cancer cells have been characterized as cells that lose their
ability to regulate growth through contact inhibition,(8) and that
lack the ability to terminally differentiate,(9) which implies a
breakdown in one of the communicating mechanisms.(2) Altera-
tion of cell-to-cell communication via gap junctions has been
implicated in the carcinogenic process and is supported by
considerable evidence.(7,10) Most cancer cells have defective
GJIC.(11) Chemical tumor promoters and oncogenes inhibit
GJIC, while tumor suppressor genes and chemopreventative
compounds enhance GJIC.(10,12) Inactivation of gap junction
genes in normal cells result in cancer-like cells,(13) and gap junc-
tion genes transfected into cancer cells restore their normal
growth regulation.(10) The knockout of the gap gene connexin
(Cx32), in mice that were administered with a single dose of the
tumor initiator, diethylnitrosamine (DEN) had a 3.3–12.8 times
increase of preneoplastic foci as compared to the DEN-treated
wild-type mice. These resultes indicate that the deletion of Cx32
promoted the carcinogenic effects of diethylnitrosamine.(14)
Cx32 knockout mice also exhibit increased levels of radiation
and chemical-induced liver and lung tumor formation.(15,16) Tumor
induction utilizing X-ray radiation resulted in a statistically
significant increase in overall tumor burden in Cx32-deficient
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mice compared with wild-type mice due to tumorigenesis in
several tissues such as the lung, liver, adrenal, lymph and small
intestine.(16) Increased levels of activated mitogen-activated pro-
tein kinases (MAPK) were also observed in these Cx32-deficient
mouse model systems compared with wild-type counterparts
implicating that MAPK-related pathways may be preferentially
activated or conversely that tumors harboring activated MAPK
pathways may selectively progressed towards more advanced
tumor states in the absence of Cx32-mediated GJIC.(16) These
results collectively indicate that Cx32 potentially play a tumor
suppressive role.
Cell proliferative diseases such as cancer not only require the
release of a quiescent cell from growth suppression via down-
regulation of GJIC and/or changes in extracellular components
(i.e. integrins), but also need to activate mitogenic signaling
pathways. The MAPK pathways are the major intracellular
signaling mechanisms by which a cell activates, via pho-
sphorylation, transcription factors involved in mitogenesis.(17–19)
Four major mitogenic cascade pathways are the following:
extracellular receptor kinase (ERK), stress activated protein
kinase/Jun N-terminal kinase, p38,(19) and ERK5/big MAPK1.(20)
The ERK-pathway has been extensively characterized and is the
most understood of the MAPK pathways.(19) The relationship
between MAPK and GJIC has not been well characterized. The
disruption of GJIC by epidermal growth factor, a mitogen,
might be mediated in part by the phosphorylation of three
serine sites of connexin43 (Cx43) via MAPK.(21) However the
phosphorylation of Cx43 alone is insufficient in the closure
of gap junction channels,(22) but phosphorylation does play
multiple roles in gap junction function and expression.(23)
We have previously reported that PAH with strict structural
criteria, specifically the existence of a bay or bay-like region,
activate ERK-MAPK and inhibit GJIC.(24–27) PAH, like polychlo-
rinated biphenyls (PCB), do not regulate GJIC through a MEK-
dependent mechanism,(25,28) which is unlike growth factors and
protein kinase C (PKC)-dependent promoters, such as 12-O-tet-
radecanoylphorbol-13-acetate (TPA).(29) We previously reported
that phosphatidylcholine-specific phospholipase C (PC-PLC) is
involved in PCB-induced inhibition of GJIC.(28) Thus, we tested
the hypothesis that PC-PLC and not MAPK is directly involved
in the regulation of GJIC by PAH. We specifically chose 1-
methylanathracene (1-MeA) and 2-methylanthracene (2-MeA)
for this study for the following reasons. Our previous studies
indicated that the 1-methyl and not the 2-methyl isomer of
anthracene inhibit GJIC and activate ERK-MAPK,(24,26,27) which
gives us an excellent model system of comparing biological
effects of two similar compounds, yet one isomer (2-MeA), can
serve as a negative control. These compounds are also environ-
mentally relevant,(30) and in particular represent a major com-
ponent of the PAH fraction of cigarette smoke.(31) In this report,
we demonstrate that 1-MeA inhibited GJIC through a PC-PLC-
dependent mechanism, and released arachidonic acid. In
addition to activating ERK-MAPK,(25) 1-MeA also activated
p38-MAPK, yet the phosphorylation patterns of Cx43 were not
altered as determined by Western blot analyzes. In contrast, the
2-MeA, did not inhibit GJIC, and did not activate ERK, p38 and
PC-PLC, nor induced the release of arachidonic acid.
Methods and Materials
Chemicals. The following are the commercial sources for the
reagents used in this study: Lucifer Yellow (Molecular Probes,
Eugene, OR, USA), sodium dodecyl sulfate (SDS), Tween 20, TRIS,
glycine, acrylamide, and TEMED (Bio-Rad Laboratories, Hercules,
CA, USA); anthracene, 1-MeA, 2-MeA, 9-MeA, RHC80267,
1-butanol, ET-18-OCH3, 4′,6-diamidino-2-phenylindole (DAPI),
p-bromophenacy/bromide (BPB) and genistein (Sigma Chemical
Co., St. Louis, MO, USA); acetonitrile (EM Science, Gibstown,
NJ, USA); PP2 (Calbiochem, LA Jolla, CA, USA); D609 (Tocris
Bioscience, Ellisville, MO, USA); H-89, BEL (Biomol Inter-
national, Plymouth Meeting, PA, USA); AACOCF3 and MAFP
(Cayman Chemical, Ann Arbor, MI, USA), all electrophoresis
reagents and the DC protein kit (Bio-Rad laboratories); phospho-
specific polyclonal antibodies directed to ERK-1 phosphory-
lated at Thr 202/Tyr204, and ERK-2 directed to phosphorylated
Thr183/Tyr185 (New England Biolabs, Ipswich, MA, USA) and
to Cx43 (Zymed Laboratories Inc., San Francisco, CA, USA),
GADPH (Chemicon, Temecula, CA, USA), and to α-tubulin
(Abcam, Cambridge, MA, USA), phosphospecific polyclonal
antip38 antibody directed to phosphorylated Thr 180/Tyr 182
(Invitrogen/Zymed, Carlsbad, CA, USA). Secondary antibodies
used were antirabbit and antimouse Ig-G conjugated with horse
radish peroxidase (Amersham, Life Science, Denver CO, USA).
The final volume of the exposure medium for each independent
culture plate was 2 mL. The concentration of each chemical is
indicated in each figure or figure legend and the vehicle for each
experiment is equivalent to the volume added with the test
compounds.
Cell culture. The WB-F344 rat liver epithelial cell line was
obtained from Drs J. W. Grisham and M. S. Tsao of the
University of North Carolina (Chapel Hill, NC, USA),(32) and
cultured in D-medium (Formula no. 78–5470EF, Gibco Labora-
tories, Grand Island, NY, USA) on 35 mm tissue culture plates
(Corning Inc., Corning, NY, USA), supplemented with 5% fetal
bovine serum (Gibco Laboratories), and incubated at 37°C in
a humidified atmosphere containing 5% CO2 and 95% air.
Bioassays were conducted with confluent cultures that were
obtained after two to three days of growth.
This cell line expresses primarily Cx43 and serves as an in
vitro cell model system for regenerative epithelial cell types that
expresses Cx43. The following are some further attributes of
this cell line. They are diploid and non-tumorigenic,(32) and have
been extensively characterized for its expressed gap junction
genes and functional GJIC using all available techniques in the
absence and presence of well-known tumor promoters, growth
factors, tumor suppressor genes and oncogenes to modulate
GJIC.(10) Intrahepatic transplantation of WB-cells into adult
syngenic F344 rats results in the morphological differentiation
of these cells into hepatocytes and incorporation into hepatic
plates.(33) The pluripotency of these cells was further demon-
strated by their differentiation into functional-contracting
cardiomyocytes when transplanted into the heart tissue of
adult syngenic F344 rats.(34)
Bioassay of GJIC. The scrape loading-dye transfer (SL-DT)
technique was adapted after the method of El-Fouly et al.(35) The
test chemicals were added directly to the cell culture medium
from concentrated stock solutions and appropriate solvent
controls were run at all times, which did not differ from
untreated cells. After treatment, cells were washed with
phosphate buffered saline (PBS) followed by the addition of
1 mg/mL of Lucifer Yellow dissolved in PBS. The dye was
introduced into the cells with three different scrapes through the
monolayer of confluent cells using a surgical steel scalpel blade.
The transfer of dye through gap junctions was for three minutes,
followed by a thorough rinse with PBS to remove extracellular
dye, and then fixed with a 4% formalin solution in PBS.
Migration of the dye in the cells was observed at 200X using a
Nikon epifluorescence microscope equipped with a Nikon Cool
Snap EZ CCD camera and the images digitally acquired using a
Nikon NIS-Elements F2.2 imaging system. The fluorescence
area of the dye migration from the scrape line was quantified
using ‘Gel Expert’ image analysis program (NucleoTech Corp,
San Mateo, CA). The data was reported as a fraction of the dye
spread of the vehicle control.
Western blot analysis. Cells were grown in 35 mm diameter
tissue culture plates from Corning (Corning, NY) to the same
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confluency as the SL-DT assay. The cells treated by the test
chemicals were done under the same conditions as those used in
the SL-DT assay. The proteins were extracted with 20% SDS
solution containing 1 mM phenylmethylsulfonyl fluoride,
100 μM Na3VO4 to the PBS, and 100 nM aprotinin, 1.0 μM
leupeptin and 1.0 μM antipain, 100 μM Na3VO4, 5.0 mM NaF.
The protein content was determined with the Bio-Rad DC assay
kit. The proteins (15 μg) were separated on 12.5% SDS-PAGE
according to the method of Laemmli.(36) The proteins were
electrophoretically transferred from the gel to polyvinylidene
fluoride (PVDF) membranes (Millipore Corp, Bedford, MA,
USA). Detection of the Western Blot signals for Cx43, p38 and
ERK used enhanced chemiluminescent (ECL) detection kit and
HyperFilm™-MP (Amersham, Life Science, Denver, CO, USA),
except for p38, we used SuperSignal West Pico Stable Peroxide
Solution and Luminol/Enhancer Solution (Pierce, Rockford, IL,
USA), film HyBlot™-CL (Denville Scientific, Metuchen, NJ,
USA).
Assay of PC-PLC and sphingomyelinase (SMase) activity.
Confluent cells in 100 mm plates, serum-deprived for 4 h, were
exposed to 1-MeA and 2-MeA at the desired concentrations for
5 and 15 min at 37°C (solvent control did not exceed 0.5% v/v).
After exposure, cells were briefly washed with ice-cold PBS,
scraped and centrifuged. The pellets (about 2.5 × 106 cells) were
lyzed for 60 min on ice with 0.6 mL of an ice cold buffer
(pH 7.5) containing 50 mM TRIS, 150 mM sodium chloride,
2 mM ethylene diamine tetraacetic acid, 1 mM ethylene glycol
tetraacetic acid, 1% v/v, Triton-X, 1 μg/mL aprotinin and
100 μg/mL phenylmethylsulfonyl fluoride. We used about
200 μL of the lysis buffer per plate. The lyzed-suspension was
centrifuged at 17 000 × g for 10 min, and the supernatant
fraction was collected and stored at –80°C for SMase and PLC
activity assays.
SMase and PC-PLC activities were determined using Amplex
Red reaction kits (Molecular Probes, Invitrogen, Eugene, OR,
USA). The assay according to Zhou et al.(37) worked as follows.
SMase and PC-PLC hydrolytic activities were determined by
the exogenous addition of their respective substrates, sphingo-
myelin (SM) or phosphatidylcholine (PC), to the thawed super-
natant fraction. Phosphocholine, the hydrolysis product of either
SM/SMase or PC/PC-PLC, was dephosphorylated with alkaline
phosphatase to choline, which was further oxidized with choline
oxidase and ambient oxygen to betaine aldehyde and hydrogen
peroxide (H2O2). The H2O2, in the presence of horseradish per-
oxidase, oxidizes Amplex Red to the fluorescent resorufin.
Reaction mixtures contained the buffer, which for SMase deter-
mination was 100 mM TRIS HCl and 10 mM magnesium chlo-
ride, pH 7.4, and for PC-PLC activity was 50 mM TRIS HCl,
140 mM NaCl, 2 mM CaCl2, pH 7.4; plus the substrates(0.5 mM SM or PC, respectively), 0.1 unit/mL choline oxidase,
5 μM Amplex Red, 4 units/mL alkaline phosphatase, 1 unit/mL
horseradish peroxidase. The kinetics of the fluorescence inten-
sity was recorded at 590 nm (excitation at 544 nm) using
Gemini microplate fluorescence reader (Molecular Devices,
Sunnyvale, CA, USA), at 37°C. The slopes were derived from
the initial 10 min of the kinetic reaction.
Assay of Arachidonic acid release. Arachidonic acid-release was
measured according to the method of Tithof et al.(38) Cells were
grown to 75% confluency in 35 mm culture dishes and then
treated for 24 h with 1.00 μCi 3[H]-arachidonic acid (specific
activity = 180–240 Ci/mM) at normal cell culture conditions. At
the end of the labeling period in which the cells have attained
95–100% confluency, the extracellular 3[H]-arachidonic acid
was removed with three washings of PBS and resuspended in
growth medium containing 0.1% bovine serum albumin (BSA)
that is arachidonic acid and phospholipid free. The BSA served
as a sink for the arachidonic acid released into the medium.(38)
The incorporation of 3[H]-arachidonic acids into the cells was
typically greater than 80%. These cells were treated with the
PAH and at the end of the treatment time the culture medium
was added to 14 mL of scintillation cocktail and counted for
radioactivity in a scintillation counter. The remaining cells were
trypsinized and solubilized in 14 mL of scintillation cocktail
and counted for radioactivity in a scintillation counter. The data
were expressed as a percentage of total cellular radioactivity
released into the medium.
Assay of immunostaining of Cx43. WB-F344 cells were cul-
tured to confluency in eight-well chamber slides (Fisher
Scientific, Pittsburgh, PA, USA). Subsequently, cells were
gently rinsed three times with PBS and fixed with 5% acetic
acid in methanol for 10 min. The non-specific binding sites were
blocked with 10% goat serum (Zymed, Carlsbad, CA, USA) for
2 h at room temperature (RT). Rabbit polyclonal Cx43 antibody
(Zymed, South San Francisco, CA, USA) was diluted 1:150 in
1% BSA +0.1% Tween-20 in PBS at 4°C for 2 h, washed three
times with 1% BSA +0.1% Tween-20 in PBS, then incubated
with Alexa Fluor 488 goat antirabbit secondary antibody
(Molecular Probes, Eugene, OR, USA) for 30 min at RT.
Negative controls were prepared by eliminating the primary/
secondary antibody. Slides were washed with PBS and counter-
stained with DAPI for 5 min before finally embedding with
Prolong Antifade kit (Molecular Probes). Fluorescent images
were obtained using a Nikon Epi-fluorescent microscope
equipped with a SPOTRT digital camera (Diagnostic Instru-
ments, Detroit, MI, USA) and analyzed with Spot Advanced
analysis software (Diagnostic Instruments).
Results
The structures of 1-MeA and 2-MeA are illustrated in Figure 1(a).
Inhibition of GJIC by 1-MeA was dose and time-dependent
(Fig. 1b). A shift of the methyl group from the 1 position, which
forms a bay-like region, to the 2 position on the anthracene ring,
which does not form a bay-like region, renders this isomer of
methylanthracene as fairly inactive relative to the inhibition
of GJIC up to 3 h, although slight inhibition was seen at 8 h.
A slight recovery was observed after a 4 h exposure time to
1-MeA, which was maintained up to 8 h. We previously
reported that 1-MeA and not 2-MeA activated ERK-MAPK,(25)
and the inhibition of GJIC was independent of this MAPK.
Similarly, 1-MeA activated p38-MAPK, while 2-MeA did not
activate p38 (Fig. 1c). Like the previous data on ERK-MAPK,(25)
activation occurred after the time period needed to inhibit GJIC,
5 min versus 10 min (Fig. 1b vs Fig. 1c). Figure 1(d) illustrates
the data for the densitometry analyzes of the p38 band. Although
there was a slight trend of 2-MeA induced phospho-p38, these
results were not significant, while the increase of the p38
bands in 1-MeA treated cells were significant (Fig. 1d).
Confirmation that the inhibition of GJIC by 1-MeA was p38-
independent is indicated in Figure 1(e) where the significant
inactivation of p38 with SB202190, a selective inhibitor of p38,
did not prevent 1-MeA from inhibiting GJIC.
Changes in the phosphorylation status of the connexin
proteins, which make up the gap junction channels, has been
implicated in the inhibition of GJIC. Our results indicate that
the various isomers of methylanthracene, including 1-, 2- and
9-methylanthracene, did not alter the phosphorylation status
of Cx43, the major connexin type in this cell line (Fig. 1f). TPA
was used as the positive control for altering the phosphorylation
status of Cx43, as indicated in a shift of the bands to higher
molecular weights and the disappearance of the P0 band. The P0
band is the unphosphorylated form of Cx43 as determined by all
bands collapsing to this position after treatment with alkaline
phosphatase.(39) This lack of an effect on the phosphorylation of
Cx43 continued even after the known activation of ERK,(25) and
p38 (Fig. 1c,d). The densitometry analysis of the three Cx43
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Fig. 1. The effects of 1-methylanthracene (1-MeA) versus 2-methylanthracene (2-MeA) on gap junction biology. (a) Structures of 1-MeA and
2-MeA; (b) Dose and time effect of 1-MeA versus 2-MeA on gap junctional intercellular communication (GJIC) activity. The data for the dose–
response were obtained from Rummel et al. in which WB-F344 rat liver epithelial cell line were treated with the indicated polycyclic aromatic
hydrocarbons (PAH) for 15 min. The dose for the time response data of each PAH was 75 μM, and the WB-F344 rat liver epithelial cell line was
used for this and all subsequent experiments. The scrape load-dye transfer assay was used to assess GJIC for both the time and dose–response
experiments. Average of the data (n = 3) ±standard deviation at the 95% confidence level. An ANOVA indicated significance at P < 0.001 for 1-
MeA dose (F = 29.1), 1-MeA time (F = 87.0), 2-MeA dose (F = 18.2), 2-MeA time (F = 15.9), and *indicated significance from the vehicle control using
a Holm Sidak posthoc T-test at the P = 0.05 level. (c) The effect of 1-MeA versus 2-MeA on the mitogen activated protein kinase, p38, as
determined by Western blot analysis of p38 using phospho-specific antibodies (top gel) and the house keeping protein α-tubulin (bottom gel).
The proteins were extracted from cells treated with 75 μM of the indicated polycyclic aromatic hydrocarbon. Anisomycin (A) at 0.5 μM and 30 min
was used as a positive control. (d) Densitometry analysis of Western blots of p38 from proteins extracted from three independently treated cell
culture plates, including the gel presented in (c). The values are the densitometry ratios of the p38 relative to α-tubulin. ANOVAs of the 10 min group
(F = 23.5, P < 0.001), 15 min group (F = 9.4, P = 0.014), 30 min group (F = 34.1, P < 0.001), 45 min group (F = 31.2, P < 0.001), indicated significance
between the vehicle, 2-MeA and 1-MeA. *Specifically indicates a difference as compared to the vehicle within each time group at P = 0.05 using
a Holm-Sidak post hoc test. (e) The effect of a p38 inhibitor on 1-MeA-induced inhibition of GJIC. The scrape loading-dye transfer assay was used
to measure GJIC. The dose and preincubation time for the p38 inhibitor, SB202190 (4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-
imidazole), were 20 μM and 20 min. The GJIC data are an average of the data (n = 3) ±standard deviation at the 95% confidence level. An ANOVA
indicated significance at P < 0.001, F = 285, and the different letters indicated significance using an all pair multiple comparison-Holm Sidak
posthoc T-test at the P = 0.05 level. (f) The effect of methylanthracene isomers on the phosphorylation status of connexin43 (Cx43). A
Western blot analysis using antiCx43 antibodies was used to identify the phosphorylated states of Cx43. The duration of exposure times to the
various PAH and vehicle were 5, 10, 20, and 30 min as indicated in the four quadrants of the figure. The quadrants are separated by the 12-O-
tetradecanoylphorbol-13-acetate (TPA) data, in which these cells were treated with TPA for 10 min. Lanes TPA = 500 ng/mL, V = vehicle (0.3% v/v
acetonitrile), A = 60 μM anthracene, 1-MeA = 60 μM 1-methylanthracene, 2-MeA = 60 μM 2-methylanthracene, 9-MeA = 60 μM 9-methylanthracene,
Recovery for top gel = 6 h recovery from cells treated with 60 μM 1-MeA for 30 min, Recovery for bottom gel = 6 h recovery from cells treated with
60 μM 9-MeA for 30 min. The 1st (bottom), 2nd and 3rd bands are typically designated P0, P1 and P2 as indicated in the boxed inset, and the
addition of alkaline phosphatase to the protein samples results in only a P0 band, using this Western blot analysis protocol. The experiment was
done in triplicate and the densitometry analyzes of the data are presented in Table 1.
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bands of three independent experiments, including data from
Figure 1(f) is presented in Table 1. ANOVA analyzes indicated
that there were no significant changes in the ratios of the P1
and P2 bands relative to P0 of all cells treated by the methylated
anthracenes, while the TPA treated cells had a significant
decrease in the P0 band relative to P1 and P2.
Connexins are commonly internalized into the cytoplasm
in response to a tumor promoter such as TPA. Similar to TPA,
Cx43 was internalized in response to 1-MeA, but not in re-
sponse to 2-MeA (Fig. 1g). However, this trafficking event
of Cx43 does not occur within 10 min, which is after the
inhibition of GJIC by either 1-MeA or TPA. Thus, inhibition of
GJIC precedes the trafficking of Cx43. However, inhibition of
PC-PLC by D609, a selective inhibitor of PC-PLC, partially
prevented the internalization of Cx43.
Phospholipases have been implicated in the regulation of
GJIC,(28) thus we measured the release of arachidonic acid from
the membranes of the cells in response to exposure to the
methyl-isomers of anthracene as an indicator of phospholipase
activation (Fig. 2a and 2b). The 1-MeA isomer induced the
release of arachidonic acid in a time and dose dependent
manner, while the 2-MeA isomer had no effect (Fig. 2a and 2b).
Significant release of arachidonic acid began at 10 μM, which
is a dose significantly lower than the dose needed to inhibit
GJIC. This release of arachidonic acid began within one minute
of treatment. Although the dose–response data suggested that
the release of arachidonic acid might not be directly involved in
the inhibition of GJIC, these data indicated that phospholipases
are activated in the same isomer-specific mode and precedes the
inhibitory events of GJIC. We have also measured the release of
arachidonic acid from WB-F344 cells by a non-radioactive high
performance liquid chromatography-fluorescence detection method,
which does not require pretreatment with 3[H]-arachidonic acid.
Our aim was to confirm that this effect of 1-MeA was not
affected by increased levels of arachidonic acid incorporated in
the membrane. In this assay, only 1-MeA was active, thus con-
firming the results of the release of 3[H]-arachidonic acid (data not
shown). PLC, which hydrolyzes the polar group of phosphoglycerol
lipids, was one class of phospholipases that we investigated for
Fig. 1 (continued). (g) Cytological localization of Cx43 in cells treated
with 1-MeA, 2-MeA and TPA. The concentrations of 1-MeA and 2-MeA
were both 70 μM, and for TPA 50 ng/mL. The vehicle was 0.3% (v/v)
acetonitrile. An antiCx43 antibody was used to label this protein. The
magnification of the images was 1000×. Ab, antibody; w/o, without.
Table 1. Densitometry scans of the phosphorylated (P1 and P2) Cx43-
bands relative to the unphosphorylated (P0) band from Western blots
of proteins extracted from three different cell treatments in which one
blot is presented in Figure 1(f)
Treatment
Densitometry Ratios of P1 and P2 Relative to P0 (FOC)
5 min 10 min 20 min 30 min
P0/P1
V 1.00 ± 0.04 1.00 ± 0.18 1.00 ± 0.08 1.00 ± 0.08
A 0.90 ± 0.12 0.99 ± 0.28 0.94 ± 0.05 0.91 ± 0.23
1-MeA 1.01 ± 0.03 1.04 ± 0.12 1.05 ± 0.12 0.97 ± 0.15
2-MeA 0.93 ± 0.05 1.05 ± 0.25 0.62 ± 0.28 0.93 ± 0.02
9-MeA 1.00 ± 0.07 1.01 ± 0.12 0.91 ± 0.01 1.12 ± 0.05
TPA ND †0.34 ± 0.16 ND ND
ANOVA
(F, P-value)
(1.73, 0.218) (4.718, 0.013) (3.468, 0.05) (1.233, 0.357)
P0/P2
V 1.00 ± 0.04 1.00 ± 0.19 1.00 ± 0.14 1.00 ± 0.17
A 0.93 ± 0.13 0.94 ± 0.28 0.95 ± 0.13 0.86 ± 0.22
1-MeA 1.03 ± 0.06 1.00 ± 0.13 1.13 ± 0.07 1.16 ± 0.25
2-MeA 0.97 ± 0.16 1.01 ± 0.26 0.54 ± 0.25 1.00 ± 0.24
9-MeA 1.05 ± 0.09 0.94 ± 0.08 1.03 ± 0.15 1.26 ± 0.33
TPA ND †0.27 ± 0.07 ND ND
ANOVA
(F, P-value)
(0.613, 0.663) (6.584, 0.004) (2.642, 097) (1.484, 0.278)
†Significant from the vehicle as determined by a Holm-Sidak post hoc 
test. The ANOVA was conducted on the densitometry data, including 
the vehicle. The fraction of the control (FOC) is the densitometry value 
of each treatment divided by the densitometry value of the vehicle 
within each time group. 1-MeA, 1-methylanthracene; 2-MeA, 
2-methylanthracene; 9-MeA, 9-methylanthracene; A, anthracene; 
Cx43, connexin43; ND, not determined; TPA, 
12-O-tetradecanoylphorbol-13-acetate; V, vehicle.
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involvement in the control of GJIC. Inhibition of phosphatidyli-
nositol specific PLC (PI-PLC) by ET-18-OCH3, a selective
inhibitor of PI-PLC, did not prevent the inhibition of GJIC by 1-
MeA (Fig. 2c,d and Table 2), however, inhibition of PC-PLC by
D609, did prevent the inhibition of GJIC by 1-MeA (Fig. 2c,d
and Table 2). Similarly, inhibition of PC-PLC with D609 also
prevented the internalization of Cx43 in response to 1-MeA treat-
ment (Fig. 1g), a downstream event to the inhibition of GJIC.
Fig. 2. The role of phospholipid signaling in 1-methylanthracene (1-MeA) versus 2-methylanthracene (2-MeA) induced effects on gap junctional
intercellular communication (GJIC). (a) The effect of 1-MeA versus 2-MeA doses on the release of arachidonic acid. (b) The effect of 1-MeA versus
2-MeA exposure times on the release of arachidonic acid. (a,b) 0.1% albumin was added to the medium to inhibit reacylation and metabolism of
released 3[H]-arachidonic acid therefore the data reflected cumulative deacylation from membrane phospholipids. At the end of the incubation
period, the medium was collected into scintillation cocktail solution and radioactivity determined by scintillation counting of disintegrations per
minute (dpm). Radioactivity in the cellular fraction was also determined, and 3[H]-fatty acid release was expressed as a percentage of total cellular
radioactivity. The data are an average of at least four independent treatments, and *indicated significant differences paired between 1-MeA and
2-MeA for each dose and time as determined by a two-tailed paired t-test at the 95% confidence interval, P < 0.001. (c) The effects of
phospholipase C (PLC) inhibitors on 1-MeA-induced inhibition of GJIC. The scrape load-dye transfer (SL-DT) assay was used to assess GJIC at 200×.
(d) Presents a summary of the averaged data of n = 3, including those shown in (c). (c,d), Phosphatidylcholine(PC)- and phosphatidylinositol(PI)-
specific-PLC were inhibited by preincubating the cells for 15 min with either 50 μM D609 or 30 μM ET-18-OCH3, respectively. The inhibitors were
left on the cells for an additional 15 min, which was the exposure time of 1-MeA. The dose of 1-MeA was 70 μM. The data are an average of the
data (n = 3) ± standard deviation at the 95% confidence level. An ANOVA indicated significance at P < 0.001, F = 420.1, and the different letters  (A,
B, C and D) indicated significance using an all pair multiple comparison-Holm Sidak posthoc T-test at the P = 0.05 level. (e) The effect of a
sphingomyelinase inhibitor on 1-MeA-induced inhibition of GJIC. The SL-DT assay was used to determine GJIC. The incubation time of 1-MeA was
15 min, and the concentration and preincubation time of the sphingomyelinase inhibitor, GW4869 (N,N′-Bis[4-(4,5-dihydro-1H-imidazol-2-
yl)phenyl]-3,3′-p-phenylene-bis-acrylamide dihydrochloride) was 40 μM and 30 min. The results are an average of the data (n = 3) ±standard
deviation at the 95% confidence level. An ANOVA indicated significance at P < 0.001, F = 3743.6, and the different letters (A, B and C) indicated
significance using an all pair multiple comparison-Holm Sidak posthoc T-test at the P = 0.05 level. (f) The effects of 1-MeA versus 2-MeA on the
activation of either PC-PLC or sphingomyelinase (SMase). An AmplexRed assay system as described in the methods and material section was used
to measure the activities of the indicated lipases. The concentration and incubation times of the PAH were 100 μM and 15 min. The results are an
average of the data (n = 5) ±standard deviation at the 95% confidence level. An ANOVA indicated significance at P = 0.003, F = 5.153, and the
*indicated significance from all other groups using an all pair multiple comparison-Holm Sidak posthoc T-test at the P = 0.05 level. (g) Intracellular
release of 3[H]-arachidonic acid from cells treated with 1-MeA and a phosphatidylcholine-specific PLC inhibitor. The extracellular media was
decanted, cells rinsed with phosphate buffered saline and then 1 mL of 0.5% bovine serum albumin in water was added to the cells for 10 min
to extract the intracellular arachidonic acid and the radioactivity was determined by scintillation counting of counts per minute (CPM). The
results are an average of the data (n = 3) ± standard deviation at the 95% confidence level. An ANOVA indicated significance at P < 0.001, F = 25.2,
and the different letters indicated significance using an all pair multiple comparison-Holm Sidak posthoc T-test at the P = 0.05 level.
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The PC-PLC inhibitor used, D609, has also been implicated
in the inhibition of SMase. Thus, we inhibited SMase with an
inhibitor specific to this enzyme (GW4869), which did not
reverse the inhibition of GJIC (Fig. 2e). Further evidence of PC-
PLC involvement is indicated by the activation of this specific
phospholipase by 1-MeA, while 1-MeA did not increase the
activity of SMase (Fig. 2f). These results indicate that D609
probably reversed the 1-MeA-induced inhibition of GJIC by
acting upon PC-PLC and not SMase. However, D609 did not
reverse the effects of 1-MeA induced release of arachidonic acid
(Fig. 2g). This suggests that the release of arachidonic acid was
not dependent on PC-PLC but rather from another phospholi-
pase. Western blot analyzes of ERK and p38 (Fig. 3a,b) demon-
strated that D609 did not reverse the activation of these MAPKs
in response to 1-MeA. Densitometry analyzes of the bands were
normalized to the house keeping protein glyceraldehyde 3-phosphate
dehydrogenase and t-tests were conducted comparing (1-MeA)
versus (1-MeA + D609) for each of the MAPK bands.
Inhibitors of other signal transduction proteins were also
preincubated with the cells before the addition of 1-MeA
(Table 2). Most significant, was inhibition of protein kinase A
(PKA) where a 72–84% recovery was observed with the follow-
ing inhibitors H89 and PKI, respectively. Several inhibitors of
PLA2 were used against the various PLA2 isoforms; particularly
sPLA2 (p-bromophenacyl bromide), cPLA2 (AACOF3 and MAFP),
iPLA2 (bromoenol lactone [BEL] and MAFPP) and acidic
iPLA2 (MJ33). BEL was the only PLA2 inhibitor that partially
reversed (26%) 1-MeA-induced closure of gap junctions, while
all other PLA2 inhibitors had no significant effect, which sug-
gests that the small BEL effect was not specific to PLA2.
Inhibitors of diacylglycerol (DAG) lipases, PLA2, PI-PLC,
phospholipase D (PLD), sphingomyelinase, PKC, Src kinases,
and protein tyrosine kinases did not prevent the inhibition of
GJIC by 1-MeA (Table 2).
Discussion
The mechanisms by which exogenous and endogenous
chemicals modulate GJIC have only been recently explored.
There are examples of modulation of GJIC at all three levels of
control: transcriptional, translational and post-translational.(40)
Phosphorylation of gap junction proteins has been the most
extensively studied post-translational modification of gap
junctions.(40) Compounds, such as phorbol esters, which activate
PKC are also known to inhibit GJIC and cause a hyper-
phosphorylation of gap junction proteins via a Mek-dependent
mechanism.(40) The hyperphosphorylation of gap junction proteins
can be detected by Western blot analysis using 1-dimensional
gel systems in which shifts in the electrophoretic bands can be
readily observed.(41) However, phosphorylation alone has been
shown to be insufficient in the regulation of GJIC.(22) Apparently,
non-phosphorylating mechanisms are also involved in the
control of GJIC,(40) which is evidently how 1-MeA is regulating
gap junctions. Our Western blot results clearly indicated that
the activation of MAPKs, such as ERK and p38, does not
necessarily result in the hyperphosphorylation of Cx43, even
though Cx43 has known consensus sequences for ERK-
MAPK.(23) We previously demonstrated that the addition of a
Mek inhibitor does not prevent the closure of gap junction
channels,(25,28) and in this report, we similarly showed that
inhibition of p38 did not reverse the effects of 1-MeA on GJIC.
Thus, activation of MAPKs, although typically required in cell
proliferation and is always accompanied with inhibition of
GJIC, does not always result in their direct control of gap
junction function.
Lipid signaling has been implicated in the control of GJIC.(42)
Lipid metabolites, such as arachidonic acid, are known to
inhibit GJIC.(43,44) Therefore, we explored the potential role of
phospholipases. The release of arachidonic acid was significantly
Table 2. Modulation of 1-MeA-induced inhibition of GJIC by various inhibitors of phospholipases and protein kinase signaling proteins
†Inhibitor Target signaling protein ‡Effect §% inhibition of GJIC
None (+1-MeA) Gap Junction ↓↓↓ 100
+D609 (50 μM, 15 min) PC-PLC ↑↑↑ *10
+H-89 (40 μM, 30 min) PKA, GPCR ↑↑ ¶28
+PKI (50 μM, 2 h) PKA ↑↑↑ ¶16
+BEL (2.5 μM, 30 min) iPLA2 ↑ ¶74
+BPB (5.0 μM, 20 min) sPLA2 ↓↓↓ 97
+AACOF3 (10 μM, 30 min) cPLA2, iPLA2 ↓↓↓ 115
+MAFP (1.25 μM, 30 min) cPLA2, iPLA2 ↓↓↓ 101
+MJ33 (10 μM, 30 min) acidic iPLA2 ↓↓↓ 104
+ET-18-OCH3 (30 μM, 30 min) PI-PLC ↓↓↓ 90
+1-butanol (0.5% v/v, 15 min) PLD ↓↓↓ 101
+RHC80267 (50 μM, 20 min) DAG lipase ↓↓↓ 97
+GF109203X (20 μM) PKC (pan-specific) ↓↓↓ 100
+PP2 (40–100 μM) Src ↓↓↓ 102
+Genistein (100 μM) Protein Tyr kinases (pan-specific) ↓↓↓ 102
†Inhibitors were added before the addition of 1-MeA, which was incubated for 15 min at 70 μM, except for the BEL experiment where the time 
of 1-MeA treatment was 30 min. The inhibitors were added at concentrations and times indicated in the parentheses, and remained in the medium 
for the duration of the experiment. D609, tricyclodecan-9-yl-xanthate; H-89,  N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide; 
BPB, p-bromophenacyl bromide; AACOCF3, arachidonyl trifluoromethylketone; PKI,  myristoylated PKI (14–22) amide; BEL, bromoenol lactone; 
MAFP, methyl arachidonyl fluorophosphates; MJ33, 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol; ET-18-OCH3, 1-O-Octadecyl-2-O-
methyl-sn-glycero-3-phosphorylcholine; RHC80267, 1,6-bis-(cyclohexyloximinocarbonylamino)hexane; GF109203X, bisindoylmaleimide I; PP2, 4-
amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine). 
‡↓↓↓ – complete inhibition of GJIC; ↑, ↑↑ – partial reversal of 1-MeA-induced inhibition of GJIC; ↑↑↑ – complete reversal of 1-MeA-induced 
inhibition of GJIC.
§An average with n = 3, % Inhibition = [(1 – FOC of Inhibitor)/(1 – FOC of vehicle)] × 100.
¶Significant as determined by a two-tailed paired t-test at the 95% confidence interval, P < 0.001 between the (1-MeA) versus (1-MeA + inhibitor) 
treated cells.
1-MeA, 1-methylanthracene; DAG, diacylglycerol; GJIC, gap junctional intercellular communication; GPCR, G-protein coupled receptor; PC-PLC, 
phosphatidylcholine specific phospholipase C; PI-PLC, phosphatidylinositol specific phospholipase C; PKA, protein kinase A; PLD, phospholipase D.
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detected within 2 min indicating that phospholipases are imme-
diately activated in response to 1-MeA. The employment of a
consortium of phospholipase inhibitors indicated that PC-PLC
was involved in 1-MeA-induced inhibition of GJIC. Inhibition
of PC-PLC by the inhibitor, D609, has also been implicated in
the inhibition of sphingomyelinase SMase, but our results
showed that a more specific SMase inhibitor did not prevent
inhibition of GJIC by 1-MeA, and the activation of PC-PLC
and not SMase by 1-MeA strongly suggested that PC-PLC was
the key regulator of GJIC in response to 1-MeA. However, PC-
PLC was involved in neither the release of arachidonic acid nor
the activation of ERK and p38 MAPKs indicating that other
phospholipases are involved in these two important signaling
events. Apparently 1-MeA either initiated a general activator
or repressed a general inhibitor of phospholipases. In contrast
to PI-PLC, the function of PC-PLC in tumorigenesis has not
been extensively studied, yet there are reports indicating that
PC-PLC does play a very significant role in cancer.(45) Our
results implicate that one significant role PC-PLC in cancer
could be the potential regulation of GJIC by environmental
agents such as certain polycyclic aromatic hydrocarbons known
to be prevalent in cigarette smoke.
Although PC-PLC was an essential component of the signal-
ing pathway controlling GJIC, this phospholipase was not
involved in arachidonic acid release indicating that other
phospholipases were activated. However, inhibition of other
phospholipases such as PI-PLC, various PLA2 isozymes, PLD
and diacylglycerol lipase did not prevent the inhibition of GJIC
by 1-MeA indicating that these lipid signaling enzymes were
not regulating GJIC. In addition, inhibition of Src kinases and
PKC, both common signaling enzymes, also did not prevent the
inhibition of GJIC by 1-MeA. The concentrations and times
used for these inhibitors of signaling enzymes were similar to
those reported in literature where an inhibitor-induced effect
was observed, but there is always the possibility of a false
negative. However, the use of several PLA2 inhibitors strongly
suggested that this class of signal transduction enzymes were
not involved in the regulation of GJIC. When cells were pre-
incubated with a PKA inhibitor, H89, a 72% recovery from
1-MeA-induced inhibition of GJIC was seen, indicating a poten-
tial role of the cAMP dependent kinase, PKA, in the regulation
of GJIC. Although H89 is known to inhibit at least eight other
kinases such as MAPKAP-K1b, S6K1, MSK1, KBα, SGK,
ROCK II, AMPK and CHK 1,(46) further experiments with the
cell permeable specific inhibitor of PKA, myristoylated PKI
(14–22) amide, also indicated the role of PKA in the down-
regulation of GJIC after exposure to 1-MeA (84% recovery of
GJIC). Another class of compounds, PCB, also inhibit GJIC
through a PC-PLC dependent mechanism, but1-MeA, unlike the
PCB did not involve Src or DAG lipase.(28)
Most research on PAH toxicity has focused on the mutagenic
and DNA damaging properties of the higher molecular weight
compounds but clearly the lower molecular weight-PAH are
capable of inducing biological effects relevant to tumor pro-
motion. We previously reported the effects of 41 different PAH
on GJIC including 16 with five or more rings.(24,27,47,48) Most of
these PAH, including the high molecular weight PAH, inhibited
GJIC with varying potencies, but the potencies of the lower
molecular weight PAH (four rings or less) tended to be much
stronger if they contained a bay or bay-like region.(6,24,27) The
low molecular weight PAH also tend to be the most abundant
in the environment.
One example is cigarette smoke, where the low molecular weight
fractions, particularly the three- and four-ringed PAH predomi-
nate in which the methylated anthracenes and phenanthrenes are
62 times higher than benzo(a)pyrene and benzo(e)pyrene.(31)
Considering that the fraction of cigarette smoke containing the
three- and four-ringed-PAH is highly cocarcinogenic when
applied to the skin of mice treated with benzo(a)pyrene,(49) and
that cigarette smoke is a strong promoter and weak complete
carcinogen,(50–53) suggest that this fraction could significantly
contribute to cancer. Ten to 15 years after giving up smoking,
the ex-smoker faces the same low risk of developing cancer of
the upper digestive tract, the lung, the pancreas, and the urinary
tract as the non-smoker.(54) This fact strongly implicates that
cigarette smoke contributes to the non-genotoxic and reversible
phases of cancer. Contribution of cigarette smoke to the non-
genotoxic phase of cancer is particularly important. Early work
on the carcinogenicity of cigarette smoke condensates strongly
indicated that the neutral fractions, which contained primarily
PAHs were the most carcinogenic fractions, but that the con-
centrations of the most prominent complete carcinogens, that is
benzo(a)pyrene, was far too low to account, by themselves, for
the carcinogenic activity of the condensates.(50,55) In addition, we
have shown that the 1-MeA, but not the 2-MeA, inhibited GJIC
Fig. 3. The effect of a phosphatidyl choline specific phospholipase C
(PC-PLC) inhibitor on 1-methylanthracene (1-MeA)-induced activation
of extracellular receptor kinase (ERK) and p38. (a) The activation of
ERK and p38 was determined by Western blot analysis using pho-
sphospecific antibodies. (b) The densitometry analyzes of the three
independent Western blot experiments including those shown in (a) of
the mitogen activated protein kinase (MAPK) bands relative to the
house keeping protein, GAPDH. (a,b) The dose and time of 1-MeA was
75 μM and 30 min. The PC-PLC inhibitor, 50 μM of D609, was added
20 min prior to 1-MeA and remained on the cells for an additional
30 min after the 1-MeA was added. The D609 control was 50 min.
The first two lanes was the vehicle. Using a two-tailed t-test, the letter
A in (b) indicates no significant difference in the p42 band between the
1-MeA and 1-MeA + D609 treatment (t = –0.548, P = 0.613). Similarly, the
letter B indicated no difference in the p44 band (t = –0.000, P = 1.000)
and the letter C indicated no difference in the p38 band (t = –0.0418,
P = 0.969) between the 1-MeA and 1-MeA + D609 treatment.
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and prevented the induction of differentiation of normal human
pancreatic cells using an in vitro system at non-cytotoxic
doses.(56) Cigarette smoking has been one of the suspected risk
factors for pancreatic cancer. Furthermore, the much less
studied area of cocarcinogenesis is a closer fit to the extended
exposure of human smoking than the complete carcinogenic
nature of selected PAH from cigarette smoke condensates.(50)
Therefore, understanding the biological effects of these three-
and four-ringed PAH, which are very prevalent in cigarette
smoke and possess cocarcinogenic activity, on cell signaling
pathways relevant to the epigenetic, non-genotoxic phase of
cancer is important. In particular, functional GJIC offers a very
central signaling system to assess risk.
The homeostasis of a tissue requires functional GJIC.
Although, the transient closure of gap junction channels during
proliferation is a normal response to mitogens, the chronic inhi-
bition of GJIC by repeated exposures to toxicants, toxins, or
cytokines released during compensatory hyperplasia could
contribute to cancer. Chronic inhibition of GJIC has been cor-
related with enhanced proliferation, and inhibition of apoptosis
and differentiation. Determining the effect of PAH on key sign-
aling and gene expression events would provide invaluable
mechanistically based information on the epigenetic toxicity
of these compounds, thereby aiding in the development of
preventative strategies of controlling human diseases such as
cancer.
Conclusion
Inhibition of GJIC and the activation of intracellular mitogenic
pathways are characteristic of epithelial derived cancer cells.
Our results indicate that PC-PLC is an important signaling
enzyme needed for the inhibition of GJIC in response to a
cigarette smoke relevant polycyclic aromatic hydrocarbon. This
report clearly indicates that specific phospholipid signaling is
involved in the regulation of GJIC, and that, in addition to
reported Mek-dependent regulation of GJIC, the regulation of
GJIC can be Mek-independent even though this MAPK pathway
is activated. Thus, not all tumor promoters inhibit GJIC through
the same signaling pathway, and this implicates that chemo-
prevention strategies relative to up-regulating GJIC activity
probably can not be universally effective.
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